CBX2 and cervical cancer: Similarly, the results of the 5-ethynyl-2′-deoxyuridine (EdU) assays revealed notably greater percentages of proliferation cells in the cervical cancer cells overexpressing CBX2 than in the control cells (Fig. 2E).